January 14, 2019What's New
December 17, 2018What's New
November 13, 2017What's New
September 18, 2017What's New
September 11, 2017What's New
June 19, 2017What's New
Our very good friend and colleague, Dr. Scott Mellis, Vice President, Early Clinical Development and Experimental Sciences, Rare Diseases at Regeneron Pharmaceuticals, took an adventurous trip to Africa and came back with some extraordinary photos.
May 30, 2017What's New
This is a must for those interested in clinical trials of the future.
May 22, 2017What's New
Last week, Target Health was honored as Dr. Jules Mitchel joined Dr. John Laschinger (FDA), for a Clinical Trials Transformation Initiative (CTTI) Webinar on CTTI's recommendations on how to design and use registries for prospective clinical trials. The Webinar attracted more than 200 participants and the questions from the attendees were all "on target." According to the CTTI website, "CTTI's recommendations for registry assessment and design can assist in making embedded clinical trials suitable for regulatory purposes. By using registries as a reusable platform for evidence generation, we can improve the efficiency of clinical trials and bring new treatments to patients faster."
April 24, 2017What's New
Warren Pearlson, our esteemed Director of Business Development, visited Iceland recently and came back with some fantastic photos the he and a colleague took. Fortunately for Target Health, Dr. Mitchel will be presenting on the topic of EHR/EDC integration in Iceland in a few weeks at the Spring meeting of the eClinical Forum. Hope to see you there.
April 17, 2017What's New
Target Health will again be attending the 16th MIXiii-BIOMED 2017 Conference and Exhibition, being held at the David Intercontinental, (May 23-25, 2017) in Tel-Aviv. This is the 16th anniversary of the conference which we have been attending since 2009. We have many clients and friends in Israel, so please let us know if you will be attending. We look forward to getting together and having a coffee.
April 10, 2017What's New
By Joyce Hays, MS and Jules Mitchel, MBA, PhD
April 3, 2017What's New
Target Health Inc. is pleased to announce that Dr. Jules Mitchel will be presenting at CBI’s 4th Annual Bootcamp on eSource Data in Clinical Investigations. The conference aims to initiate meaningful dialogues around early successes, failures and pain points through collaborative sessions and investigative case studies so that you can build an eSource adoption business case for senior leadership addressing balance of risk and cost.
March 20, 2017What's New
Target Health Inc. is pleased to announce that Dr. Jules Mitchel will be presenting at CBI's 4th Annual Bootcamp on eSource Data in Clinical Investigations. The conference aims to initiate meaningful dialogues, through collaborative sessions and investigative case studies, around early successes, challenges and failures, so that one can build an eSource adoption business case for senior leadership addressing balance of risk and cost.
March 13, 2017What's New
The photo below was taken in the front gardens of our building in NYC showing the crocuses pushing through.
March 6, 2017What's New
Target Health Website has a new look, although the banner designed by CEO Joyce Hays, remains as well as the famous Leaping Dog, a feature of our website from inception. We are also very proud of our publications, many of which are prescient and trailblazing.
February 13, 2017What's New
This week it snowed all morning in NYC followed by a beautiful clear evening. Before sunset, we were joined by our good friend and colleague, Silvana Cappi, VP Biometrics, at Ferring Pharmaceuticals who took this spectacular photo of the East River looking North. Can you see the snow and what looks like a palm tree? Also, if you look carefully, you can see the UN building in the background.
February 6, 2017What's New
Target Health has been on the 23rd and 24 Floors at 261 Madison since 2001. There are a lot of breath-taking views at sunset which we have shared for many years, but this morning view of shadows, the spectacular sky and eclectic architecture, has left us breathless.